Editorial: real-life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease

Aliment Pharmacol Ther. 2018 Jul;48(2):226-227. doi: 10.1111/apt.14792.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amides
  • Antiviral Agents*
  • Benzofurans
  • Carbamates
  • Cyclopropanes
  • Hepatitis C, Chronic*
  • Humans
  • Imidazoles
  • Kidney Diseases*
  • Quinoxalines
  • Retrospective Studies
  • Sulfonamides

Substances

  • Amides
  • Antiviral Agents
  • Benzofurans
  • Carbamates
  • Cyclopropanes
  • Imidazoles
  • Quinoxalines
  • Sulfonamides
  • grazoprevir
  • elbasvir